Junliang Pu

616 total citations
22 papers, 447 citations indexed

About

Junliang Pu is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Junliang Pu has authored 22 papers receiving a total of 447 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 8 papers in Surgery and 8 papers in Cancer Research. Recurrent topics in Junliang Pu's work include MicroRNA in disease regulation (6 papers), Organ Transplantation Techniques and Outcomes (6 papers) and Inflammasome and immune disorders (4 papers). Junliang Pu is often cited by papers focused on MicroRNA in disease regulation (6 papers), Organ Transplantation Techniques and Outcomes (6 papers) and Inflammasome and immune disorders (4 papers). Junliang Pu collaborates with scholars based in China. Junliang Pu's co-authors include Zhongjun Wu, Tong Mou, Zuotian Huang, Xufu Wei, Daofeng Zheng, Zhen Guo, Yunhai Luo, Di Zhu, Tingting Li and Qingsong Chen and has published in prestigious journals such as Scientific Reports, Life Sciences and Cell Death and Disease.

In The Last Decade

Junliang Pu

22 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junliang Pu China 11 243 124 92 91 89 22 447
Zuotian Huang China 14 276 1.1× 112 0.9× 120 1.3× 89 1.0× 159 1.8× 38 524
Yunwei Guo China 11 231 1.0× 170 1.4× 67 0.7× 114 1.3× 51 0.6× 28 462
Xixi Cheng China 9 362 1.5× 224 1.8× 104 1.1× 132 1.5× 52 0.6× 15 621
Baoyong Zhou China 12 238 1.0× 100 0.8× 73 0.8× 92 1.0× 74 0.8× 40 481
Ibone Labiano Spain 7 289 1.2× 108 0.9× 91 1.0× 65 0.7× 46 0.5× 10 493
Tixiao Wang China 12 290 1.2× 128 1.0× 73 0.8× 123 1.4× 257 2.9× 18 654
John Stoops United States 11 247 1.0× 48 0.4× 93 1.0× 161 1.8× 59 0.7× 16 493
Elisa Manieri Spain 10 292 1.2× 71 0.6× 80 0.9× 126 1.4× 79 0.9× 12 629
Brian Bridges United States 7 193 0.8× 49 0.4× 62 0.7× 123 1.4× 74 0.8× 8 389
Louise Tzung-Harn Hsieh Germany 10 235 1.0× 83 0.7× 43 0.5× 91 1.0× 141 1.6× 14 523

Countries citing papers authored by Junliang Pu

Since Specialization
Citations

This map shows the geographic impact of Junliang Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junliang Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junliang Pu more than expected).

Fields of papers citing papers by Junliang Pu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junliang Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junliang Pu. The network helps show where Junliang Pu may publish in the future.

Co-authorship network of co-authors of Junliang Pu

This figure shows the co-authorship network connecting the top 25 collaborators of Junliang Pu. A scholar is included among the top collaborators of Junliang Pu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junliang Pu. Junliang Pu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Rui, Lei Wan, Junliang Pu, et al.. (2025). Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4 , a novel once‐weekly basal insulin, in healthy participants: A randomized trial. Diabetes Obesity and Metabolism. 27(5). 2515–2522. 1 indexed citations
2.
3.
Zhang, Ting, et al.. (2023). Safety, tolerability, and pharmacokinetics of oral (S)-oxiracetam in Chinese healthy volunteers: A randomized, double-blind, controlled phase I study. European Journal of Pharmaceutical Sciences. 192. 106621–106621. 2 indexed citations
4.
Huang, Zuotian, Junliang Pu, Yunhai Luo, et al.. (2022). FAM49B, restrained by miR-22, relieved hepatic ischemia/reperfusion injury by inhibiting TRAF6/IKK signaling pathway in a Rac1-dependent manner. Molecular Immunology. 143. 135–146. 18 indexed citations
5.
Li, Tingting, Zuotian Huang, Yunhai Luo, et al.. (2022). MicroRNA-141-3p attenuates oxidative stress-induced hepatic ischemia reperfusion injury via Keap1/Nrf2 pathway. Molecular Biology Reports. 49(8). 7575–7585. 6 indexed citations
6.
7.
8.
Luo, Yunhai, Zuotian Huang, Tong Mou, et al.. (2021). SET8 mitigates hepatic ischemia/reperfusion injury in mice by suppressing MARK4/NLRP3 inflammasome pathway. Life Sciences. 273. 119286–119286. 22 indexed citations
9.
Pu, Junliang, Zuotian Huang, Yunhai Luo, et al.. (2021). Fisetin mitigates hepatic ischemia-reperfusion injury by regulating GSK3β/AMPK/NLRP3 inflammasome pathway. Hepatobiliary & pancreatic diseases international. 20(4). 352–360. 34 indexed citations
10.
Luo, Yunhai, Daofeng Zheng, Tong Mou, et al.. (2021). CMPK2 accelerates liver ischemia/reperfusion injury via the NLRP3 signaling pathway. Experimental and Therapeutic Medicine. 22(6). 1358–1358. 13 indexed citations
11.
Chen, Wei, Daofeng Zheng, Tong Mou, et al.. (2020). Tle1 attenuates hepatic ischemia/reperfusion injury by suppressing NOD2/NF-κB signaling. Bioscience Biotechnology and Biochemistry. 84(6). 1176–1182. 11 indexed citations
12.
Huang, Zuotian, Tong Mou, Yunhai Luo, et al.. (2020). Inhibition of miR-450b-5p ameliorates hepatic ischemia/reperfusion injury via targeting CRYAB. Cell Death and Disease. 11(6). 455–455. 78 indexed citations
13.
Mou, Tong, Yunhai Luo, Zuotian Huang, et al.. (2020). Inhibition of microRNA-128-3p alleviates liver ischaemia–reperfusion injury in mice through repressing the Rnd3/NF‐κB axis. Innate Immunity. 26(6). 528–536. 20 indexed citations
14.
Yan, Yue, Daofeng Zheng, Junliang Pu, & Zhongjun Wu. (2019). Outcomes of adult patients adopting small-for-size grafts in living donor liver transplantation: A systematic review and meta-analysis. Hepatobiliary & pancreatic diseases international. 18(3). 206–213. 4 indexed citations
15.
Li, Tingting, Di Zhu, Tong Mou, et al.. (2017). IL-37 induces autophagy in hepatocellular carcinoma cells by inhibiting the PI3K/AKT/mTOR pathway. Molecular Immunology. 87. 132–140. 78 indexed citations
16.
Mou, Tong, Di Zhu, Xufu Wei, et al.. (2017). Identification and interaction analysis of key genes and microRNAs in hepatocellular carcinoma by bioinformatics analysis. World Journal of Surgical Oncology. 15(1). 63–63. 42 indexed citations
17.
Li, Tingting, et al.. (2017). [Interleukin-37 induces apoptosis and autophagy of SMMC-7721 cells by inhibiting phosphorylation of mTOR].. PubMed. 33(4). 440–445. 2 indexed citations
18.
Pu, Junliang, Lei Wan, Daofeng Zheng, et al.. (2017). [Fisetin alleviates hypoxia/reoxygenation injury in rat hepatocytes via modulation of TLR4/NF-κB signaling pathway].. PubMed. 33(7). 936–941. 1 indexed citations
19.
Wei, Xufu, Junliang Pu, Zhen Guo, et al.. (2017). [Tumor-associated macrophages promote the proliferation and migration as well as invasion of sorafenib-resistant hepatocellular carcinoma cells].. PubMed. 33(5). 617–622. 6 indexed citations
20.
Guo, Zhen, Junliang Pu, Daofeng Zheng, et al.. (2016). Resveratrol preconditioning protects hepatocytes against hepatic ischemia reperfusion injury via Toll-like receptor 4/nuclear factor-κB signaling pathway in vitro and in vivo. International Immunopharmacology. 35. 201–209. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zuotian Huang Breakdown of academic impact, for papers by Yunwei Guo Breakdown of academic impact, for papers by Xixi Cheng Breakdown of academic impact, for papers by Baoyong Zhou Breakdown of academic impact, for papers by Ibone Labiano Breakdown of academic impact, for papers by Tixiao Wang Breakdown of academic impact, for papers by John Stoops Breakdown of academic impact, for papers by Elisa Manieri Breakdown of academic impact, for papers by Brian Bridges Breakdown of academic impact, for papers by Louise Tzung-Harn Hsieh
Rankless by CCL
2026